Continued from previous page
tonidou from Greece will present
new recommendations on the management of adult antiphospholipid
antibody syndrome. She will outline
how to treat the disease based on
antibodies and provide delegates
with a lot of recommendations that
they can use in their daily clinical
“One has learned that, if you have
low titres, it’s a completely different
situation than if you have high titres.
... There are some drugs which can
inhibit or decrease the amount of
antibodies, like antimalarials or rituximab, and that will also be addressed,
as well as obstetric care and the role
of different anticoagulants,” Prof.
Standing Committee on Epidemiology
and Health Services Research
The Friday afternoon session from
the Standing Committee on Epide-
in three diseases
and also is worth
watching out for
this year, accord-
ing to committee
chair Prof. Laure
Gossec of the
Pitié Salpêtrière Hospital in Paris.
It will be chaired by Dr. Sofia
Ramiro from the Netherlands and
Prof. Bernard Combe from France
and will open with a presentation by
Dr. Daniel Aletaha from Austria on
whether the definition of remission in
RA matters. Next, Prof. Pedro Machado from the United Kingdom will talk
about remission in axial spondyloar-thritis, and Prof. Marta Mosca from
Italy will address remission in SLE.
At the same session, Prof. Eric
Morand from Australia will present
the latest results from the definitions
of remission in SLE group, and Dr.
Signe Møller-Bisgaard from Denmark
will present results on MRI damage
progression in RA patients in clinical
Standing Committee on
For Thursday, the Standing Commit-
tee on Investigative Rheumatology
has organised a session on “Big data
and the disruption of medical care.”
Prof. Harald Schmidt from the
Netherlands will enlighten the crowd
on how medicine as we know it – in
is provided on
the basis of a
diagnosis – is
going to turn
of what this will
look like will be
provided by Prof.
Anke-Hilse Maitland-van der Zee from
the Netherlands and Prof. Ken Smith
from the United Kingdom.
“This session will truly provide a
glimpse into the future with regards
to the daily care of patients with
RMDs [rheumatic and musculoskeletal diseases],” said Prof. Timothy
Radstake from the Netherlands, who
is chair of the committee.
Lastly, the committee will copre-sent its big data project with the
Standing Committee on Epidemiology and Health Services Research.
According to both Prof. Gossec and
Prof. Radstake, the project is a standout because it is the first EULAR-endorsed “points to consider” for the
use of big data in RMDs.
The use of big data by artificial
intelligence, computational modelling, and machine learning is a rapidly
evolving field with the potential to
profoundly modify RMD research and
patient care, noted Prof. Gossec, who
is a first author on the work.
“These points will address key issues including ethics, data sources,
data storage, data analyses, artificial
intelligence [such as computational
modelling and machine learning], the
need for benchmarking, adequate reporting of methods, and implementation of findings into clinical practice,”
she said in an interview.
“Molecular profiling of RMDs and
installing treatment accordingly is
going to be truly transformative for
the field. This session will unveil a
glimpse of the future, which is closer
than you think,” Prof. Radstake said.
Standing Committee on
It has also been another busy year for
the Standing Committee on Musculoskeletal Imaging (ESCMI), according
to its chair, Dr. Xenofon Baraliakos
“On the one side, we have focused
on the continu-
ation and termi-
nation of the
were started and
conducted in the
and on the other
side, we have
started new proj-
ects that enhance the evidence level
of recommendations for using imag-
ing in RMDs,” he said in an interview.
One standout achievement by the
committee was the initiation of an
online imaging course that came to
fruition this year in collaboration with
the EULAR School of Rheumatology.
“This is the first full on-line course
on a completely new learning management system, and it is setting the
standards for further courses based
on an online-only experience, ” he said.
On Saturday, the committee will
present its main projects, including
the development of a standardised
training model for ultrasound-guided
synovial biopsies in small and large
joints, EULAR recommendations
for reporting in musculoskeletal
ultrasound studies, and the implementation and role of modern musculoskeletal imaging in rheumatologic
practice in Europe.
According to Dr. Baraliakos, the
ESCMI is one of the most active committees for educational sessions during
the congress, with its imaging courses
available prior to the congress and
many ultrasound and MRI courses also
offered throughout the congress.